Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Study Helps Explain Chronic Inflammation in Colon Cancer
Disease Discoveries

Study Helps Explain Chronic Inflammation in Colon Cancer

By Sarah PlumridgeJul 10, 2014
Share
Facebook Twitter Email
David Bentrem, MD, MSCI GME’03, and his collaborators uncovered how beta-catenin signaling in certain T-cells contributes to intestinal inflammation and colon cancer in patients and mice with underlying colitis.

A multi-disciplinary team of scientists from Northwestern Medicine and the University of Chicago investigated how lymphocytes, a type of white blood cell, increase inflammation in the body during colon cancer.

Of cancers that affect both men and women, colon cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and women, according to the National Cancer Center at the National Institutes of Health. The number and type of lymphocytes that penetrate colon tumors affect the clinical outcomes of patients.

David Bentrem, MD, MSCI GME’03, Harold L. and Margaret N. Method Research Professor in Surgery, in collaboration with Khash Khazaie, PhD, a member of the Robert H. Lurie Comprehensive Cancer Center, previously identified a subset of regulatory T-cells, a type of lymphocyte, which cause an increase in inflammation in tumor samples from colon cancer patients.

In this new study, investigators combined data from patients who have colon cancer with mouse model studies of the disease to uncover the molecular mechanism behind the abnormal behavior of these T-cells. Their findings were recently published in Science Translational Medicine.

It is well known that varying numbers and types of lymphocytes infiltrate colon tumors, yet the role they play in cancer progression is not fully understood.

“More than half of the cells in solid tumors aren’t cancer cells, so we wanted to understand what these cells are doing and if they influence outcomes in colon cancer patients,” said Dr. Bentrem, who collaborated with Fotini Gounari, PhD, at the University of Chicago on the project. “We took tumors out of patients, isolated the lymphocytes, and were able to find subsets of regulatory T-cells that promoted inflammation. Next, the team focused on how these cells became pro-inflammatory.”

Using mouse models, they found that when high levels of beta-catenin, a regulatory protein, were expressed in T-cells, the mice were highly susceptible to colon cancer. This confirmed the role the protein plays in promoting the disease and shows how it contributes to intestinal inflammation and colon carcinogenesis in those with underlying colitis.

These results allow physicians to not only understand how inflammation in colon cancer occurs, but also provide insight into ways to create more effective treatment plans for patients.

Other collaborators on the project from Northwestern University Feinberg School of Medicine include Mary Mulcahy, MD, associate professor in Medicine-Hematology/Oncology, Radiology and Surgery-Organ Transplantation and a member of the Lurie Cancer Center; Vysak Venkateswaran, a biotechnology graduate student; and Elena M. Ramos, senior research study coordinator.

The study was supported by National Institutes of Health grants R21AI076720, 1R01CA160436 and P30-DK42086, American Cancer Society grant ACS/RSG-LIB-113428, Circle of Service award from the Robert H. Lurie Comprehensive Cancer Center and T32HL007381 Cardiovascular Sciences Training Grant.

Cancer Research Surgery
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.